Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2001 1
2004 2
2005 3
2006 1
2007 2
2008 8
2009 7
2010 12
2011 15
2012 20
2013 23
2014 22
2015 40
2016 56
2017 41
2018 36
2019 39
2020 17
2021 27
2022 24
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26275367

335 results

Results by year

Filters applied: . Clear all
Page 1
Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.
Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH. Chu HH, et al. Radiology. 2013 Dec;269(3):831-40. doi: 10.1148/radiol.13122024. Epub 2013 Oct 28. Radiology. 2013. PMID: 23771912
Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy.
Nam JG, Kang KM, Choi SH, Lim WH, Yoo RE, Kim JH, Yun TJ, Sohn CH. Nam JG, et al. AJNR Am J Neuroradiol. 2017 Dec;38(12):2243-2250. doi: 10.3174/ajnr.A5417. Epub 2017 Oct 26. AJNR Am J Neuroradiol. 2017. PMID: 29074633 Free PMC article.
Pseudoprogression and treatment effect.
Jahangiri A, Aghi MK. Jahangiri A, et al. Neurosurg Clin N Am. 2012 Apr;23(2):277-87, viii-ix. doi: 10.1016/j.nec.2012.01.002. Epub 2012 Feb 14. Neurosurg Clin N Am. 2012. PMID: 22440871 Review.
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M. Brandes AA, et al. J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163. J Clin Oncol. 2008. PMID: 18445844
Population-based study of pseudoprogression after chemoradiotherapy in GBM.
Roldán GB, Scott JN, McIntyre JB, Dharmawardene M, de Robles PA, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross JG, Hamilton MG, Easaw JC. Roldán GB, et al. Can J Neurol Sci. 2009 Sep;36(5):617-22. doi: 10.1017/s0317167100008131. Can J Neurol Sci. 2009. PMID: 19831132 Clinical Trial.
335 results